{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:44:12Z","timestamp":1781498652285,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Grant 303325\/2017-8"],"award-info":[{"award-number":["Grant 303325\/2017-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Edital MCT\/CNPq 14\/2010"],"award-info":[{"award-number":["Edital MCT\/CNPq 14\/2010"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","award":["MCTI\/CNPq 14\/2013"],"award-info":[{"award-number":["MCTI\/CNPq 14\/2013"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"funda\u00e7\u00e3o de amparo \u00e0 pesquisa do estado de s\u00e3o paulo","doi-asserted-by":"publisher","award":["Grant 2015\/12308-5"],"award-info":[{"award-number":["Grant 2015\/12308-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"coordena\u00e7\u00e3o de aperfei\u00e7oamento de pessoal de n\u00edvel superior","doi-asserted-by":"publisher","award":["PNPD\/CAPES"],"award-info":[{"award-number":["PNPD\/CAPES"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00213-023-06350-6","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T19:02:52Z","timestamp":1679684572000},"page":"1131-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic effects in a progressive model of parkinsonism induced by reserpine"],"prefix":"10.1007","volume":"240","author":[{"given":"Guilherme Pasetto","family":"Fadanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson Henrique Fran\u00e7a Figueiredo","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalli","family":"Granzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Guimar\u00e3es","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auderlan Mendon\u00e7a","family":"de Gois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e2mela Andressa Ramborger","family":"Anjos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1urea Elizabeth","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ronaldo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Helena","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-2923","authenticated-orcid":false,"given":"Geison Souza","family":"Iz\u00eddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"2","key":"6350_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2004.04.003","volume":"47","author":"VC Ab\u00edlio","year":"2004","unstructured":"Ab\u00edlio VC, Silva RH, Carvalho RC, Grassl C, Calzavara MB, Registro S, D\u2019almeida V, Ribeiro RA, Frussa-Frilho R (2004) Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia. Neuropharmacology 47(2):263\u2013272","journal-title":"Neuropharmacology"},{"key":"6350_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0091-3057(97)00457-7","volume":"59","author":"M Angrini","year":"1998","unstructured":"Angrini M, Leslie JC, Shephard RA (1998) Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior. Pharmacol Biochem Behav 59:387\u2013397","journal-title":"Pharmacol Biochem Behav"},{"key":"6350_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nlm.2016.03.024","volume":"131","author":"M Anselmi","year":"2016","unstructured":"Anselmi M, Correa FJ, Santos JR, Silva AF, Cunha JA, Le\u00e3o AH, Camp\u00ealo CL, Ribeiro AM, Silva RH, Izidio GS (2016) Genetic evidence for chromosome 4 loci influencing learning and memory. Neurobiol Learn Mem 131:182\u2013191","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"6350_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12640-013-9454-8","volume":"26","author":"L Antkiewicz-Michaluk","year":"2014","unstructured":"Antkiewicz-Michaluk L, Wasik A, Mozdzen E, Romanska I, Michaluk J (2014) Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox Res 26(1):85\u201398","journal-title":"Neurotox Res"},{"key":"6350_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ (2011) Properties of native brain \u03b1-synuclein. Nature 477:107\u2013110","journal-title":"Nature"},{"issue":"4","key":"6350_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0091-3057(00)00412-3","volume":"67","author":"B Bennett","year":"2000","unstructured":"Bennett B (2000) Congenic strains developed for alcohol- and drug-related phenotypes. Pharmacol Biochem Behav 67(4):671\u2013681","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"6350_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington clinical, morphological and neurochemical correlations. J Neurol Sci 20(4):415\u2013455","journal-title":"J Neurol Sci"},{"key":"6350_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbr.2019.01.041","volume":"363","author":"JMM Bispo","year":"2019","unstructured":"Bispo JMM, Melo JEC, Gois AM, Leal PC, Lins LCRF, Souza MF, Medeiros KAAL, Ribeiro AM, Silva RH, Marchioro M, Santos JR (2019) Sex differences in the progressive model of parkinsonism induced by reserpine in rats. Behav Brain Res 363:23\u201329","journal-title":"Behav Brain Res"},{"issue":"10","key":"6350_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/acn3.246","volume":"2","author":"C Buddhala","year":"2015","unstructured":"Buddhala C, Loftin SK, Kuley BM, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT (2015) Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Ann Clin Transl Neurol. 2(10):949\u201359","journal-title":"Ann Clin Transl Neurol."},{"key":"6350_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fnagi.2017.00198","volume":"9","author":"CLC Camp\u00ealo","year":"2017","unstructured":"Camp\u00ealo CLC, Cagni FC, De Siqueira Figueredo D, Oliveira LG Jr, Silva-Neto AB, Mac\u00eado PT, Santos JR, Iz\u00eddio GS, Ribeiro AM, De Andrade TG, De Oliveira Godeiro CJR, Silva RH (2017) Variants in SNCA gene are associated with Parkinson\u2019s disease risk and cognitive symptoms in a Brazilian sample. Front Aging Neurosci. 9:198","journal-title":"Front Aging Neurosci."},{"key":"6350_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141146","volume":"48","author":"FA Chaudhry","year":"2008","unstructured":"Chaudhry FA, Edwards RH, Fonnum F (2008) Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. Annu Rev Pharmacol Toxicol 48:277\u2013301","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"6350_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/mp.2008.43","volume":"14","author":"S Chiavegatto","year":"2009","unstructured":"Chiavegatto S, Izidio GS, Mendes-Lana A, Aneas I, Freitas TA, Torr\u00e3o AS, Concei\u00e7\u00e3o IM, Britto LRG, Ramos A (2009) Expression of alpha-synuclein is increased in the hippocampus of rats with high levels of innate anxiety. Mol Psychiatry 14(9):894\u2013905","journal-title":"Mol Psychiatry"},{"issue":"4","key":"6350_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/HYPERTENSIONAHA.108.126649","volume":"53","author":"GT Cicila","year":"2009","unstructured":"Cicila GT, Morgan EE, Lee SJ, Farms P, Yerga-Woolwine S, Toland EJ, Ramdath RS, Gopalakrishnan K, Bohman K, Nestor-Kalinoski AL, Khuder SA, Joe B (2009) Epistatic genetic determinants of blood pressure and mortality in a salt-sensitive hypertension model. Hypertension (Dallas, Tex.: 1979) 53(4):725\u2013732","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"6350_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.03.001","volume":"171","author":"RR Cintra","year":"2021","unstructured":"Cintra RR, Lins LCRF, Medeiros KAAL, Souza MF, Gois AM, Bispo JMM, Melo MS, Leal PC, Meurer YSR, Ribeiro AM, Silva RH, Marchioro M, Santos JR (2021) Nociception alterations precede motor symptoms in a progressive model of parkinsonism induced by reserpine in middle-aged rats. Brain Res Bull 171:1\u20139","journal-title":"Brain Res Bull"},{"issue":"2","key":"6350_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","volume":"40","author":"JC Corona","year":"2015","unstructured":"Corona JC, Duchen MR (2015) PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson\u2019s. Neurochem Res 40(2):308\u2013316","journal-title":"Neurochem Res"},{"key":"6350_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona JC, Duchen MR (2016) PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 100:153\u2013163","journal-title":"Free Radic Biol Med."},{"issue":"12","key":"6350_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083666","volume":"8","author":"GF De Medeiros","year":"2013","unstructured":"De Medeiros GF, Pereira E, Granzotto N, Ramos A (2013) Low-anxiety rat phenotypes can be further reduced through genetic intervention. PLoS One\u00a08(12):e83666","journal-title":"PLoS ONE"},{"issue":"3","key":"6350_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4236\/wjns.2014.43024","volume":"4","author":"GF De Medeiros","year":"2014","unstructured":"De Medeiros GF, Corr\u00eaa FJ, Corvino ME, Izidio GS, Ramos A (2014) The long way from complex phenotypes to genes: the story of rat chromosome 4 and its behavioral effects. World J Neurosci 4(3):203\u2013215","journal-title":"World J Neurosci"},{"issue":"4","key":"6350_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3(4):461\u2013491","journal-title":"J Parkinsons Dis"},{"key":"6350_CR20","doi-asserted-by":"publisher","first-page":"111198","DOI":"10.1016\/j.exger.2020.111198","volume":"145","author":"TFO Dos Santos","year":"2021","unstructured":"Dos Santos TFO, De R Santos E, Bispo JMM, De Souza MF, De Gois AM, Lins LCRF, Silva RH, Ribeiro AM, Marchioro M, Dos Santos JR (2021) Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats. Exp Gerontol 145:111198","journal-title":"Exp Gerontol"},{"issue":"4","key":"6350_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty S, Jenner P (2011) Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164(4):1357\u20131391","journal-title":"Br J Pharmacol"},{"issue":"10","key":"6350_CR22","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1073\/pnas.93.10.5166","volume":"93","author":"JD Erickson","year":"1996","unstructured":"Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A 93(10):5166\u20135171","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6350_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","volume":"231","author":"VS Fernandes","year":"2012","unstructured":"Fernandes VS, Santos JR, Le\u00e3o AH, Medeiros AM, Melo TG, Iz\u00eddio GS, Cabral A, Ribeiro RA, Ab\u00edlio VC, Ribeiro AM, Silva RH (2012) Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease. Behav Brain Res 231(1):154\u2013163","journal-title":"Behav Brain Res"},{"key":"6350_CR24","doi-asserted-by":"crossref","unstructured":"Gallegos S, Pacheco C, Peters C, Opazo CM, Aguayo LG (2015) Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson\u2019s disease. Front Neurosci 9:59. eCollection 2015.","DOI":"10.3389\/fnins.2015.00059"},{"issue":"5","key":"6350_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","volume":"123","author":"MN Gaugler","year":"2012","unstructured":"Gaugler MN, Genc O, Bobela W, Mohanna S, Ardah MT, El-Agnaf OM, Cantoni M, Bensadoun JC, Schneggenburguer R, Knott GW, Aebischer P, Schneider BL (2012) Nigrostriatal overabundance of \u03b1-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol 123(5):653\u2013669","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6350_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbr.2005.10.019","volume":"168","author":"FR Hinojosa","year":"2006","unstructured":"Hinojosa FR, Spricigo L, Iz\u00eddio GS et al (2006) Evaluation of two genetic animal models in behavioral tests of anxiety and depression. Behav Brain Res 168(1):127\u2013136","journal-title":"Behav Brain Res"},{"issue":"3","key":"6350_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger KA (1991) Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14(3):153\u2013197","journal-title":"Mol Chem Neuropathol"},{"key":"6350_CR28","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","volume":"66","author":"P Jenner","year":"2006","unstructured":"Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson\u2019s disease. Neurology 66:S24\u2013S36","journal-title":"Neurology"},{"issue":"1","key":"6350_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00441-004-0975-6","volume":"318","author":"T Klockgether","year":"2004","unstructured":"Klockgether T (2004) Parkinson\u2019s disease: clinical aspects. Cell Tissue Res 318(1):115\u2013120","journal-title":"Cell Tissue Res"},{"key":"6350_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"issue":"1","key":"6350_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0741-8329(01)00193-8","volume":"26","author":"CJ Labuda","year":"2002","unstructured":"Labuda CJ, Fuchs PN (2002) Catecholamine depletion by reserpine blocks the anxiolytic actions of ethanol in the rat. Alcohol 26(1):55\u201359","journal-title":"Alcohol"},{"issue":"4","key":"6350_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/bpa.12253","volume":"25","author":"AH Le\u00e3o","year":"2015","unstructured":"Le\u00e3o AH, Sarmento-Silva AJ, Santos JR, Ribeiro AM, Silva RH (2015) Molecular, neurochemical, and behavioral hallmarks of reserpine as a model for Parkinson\u2019s disease: new perspectives to a long-standing model. Brain Pathol 25(4):377\u2013390","journal-title":"Brain Pathol"},{"key":"6350_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2017.00078","volume":"9","author":"AH Le\u00e3o","year":"2017","unstructured":"Le\u00e3o AH, Meurer YS, Da Silva AF, Medeiros AM, Camp\u00ealo CL, Ab\u00edlio Vc, Engelberth RC, Cavalcante JS, Iz\u00eddio GS, Ribeiro AM, Silva RH (2017) Spontaneously hypertensive rats (SHR) are resistant to a reserpine-induced progressive model of Parkinson\u2019s disease: differences in motor behavior, tyrosine hydroxylase and \u03b1-synuclein expression. Front Aging Neurosci 9:78","journal-title":"Front Aging Neurosci"},{"key":"6350_CR34","doi-asserted-by":"publisher","first-page":"113349","DOI":"10.1016\/j.bbr.2021.113349","volume":"410","author":"AH Le\u00e3o","year":"2021","unstructured":"Le\u00e3o AH, Meurer YS, Freitas TA, Medeiros AM, Ab\u00edlio VC, Iz\u00eddio GS, Concei\u00e7\u00e3o IM, Ribeiro AM, Silva RH (2021) Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and spontaneously hypertensive rats (SHR): implications for cognitive deficits in a progressive animal model for Parkinson\u2019s disease. Behav Brain Res 410:113349","journal-title":"Behav Brain Res"},{"issue":"9680","key":"6350_CR35","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373(9680):2055\u20132066","journal-title":"Lancet"},{"issue":"1","key":"6350_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/01.gim.0000250507.96760.4b","volume":"9","author":"D Li","year":"2007","unstructured":"Li D, He L (2007) Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med 9(1):4\u20138","journal-title":"Genet Med"},{"key":"6350_CR37","doi-asserted-by":"publisher","unstructured":"Lima AC, Meurer YRS, Bioni VS, Cunha DMG, Gon\u00e7alves N, Lopes-Silva LB, Becegato M, Soares MBL, Marinho GF, Santos JR, Silva, RH (2021) Female Rats Are Resistant to Cognitive Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson\u2019s Disease Frontiers in Aging Neuroscience 13. https:\/\/doi.org\/10.3389\/fnagi.2021.757714","DOI":"10.3389\/fnagi.2021.757714"},{"key":"6350_CR38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"6350_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.beproc.2017.06.001","volume":"142","author":"FG Mazur","year":"2017","unstructured":"Mazur FG, Oliveira LFG, Cunha MP, Rodrigues ALS, Ran P, Vendruscolo LF, Iz\u00eddio GS (2017) Effects of physical exercise and social isolation on anxiety-related behaviors in two inbred rat strains. Behav Processes 142:70\u201378","journal-title":"Behav Processes"},{"issue":"9766","key":"6350_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","volume":"377","author":"MA Nalls","year":"2011","unstructured":"Nalls MA, Plagnol V, Hernandez DG et al (2011) International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet 377(9766):641\u2013649","journal-title":"Lancet"},{"key":"6350_CR41","unstructured":"Paxinos\u00a0G, Watson\u00a0C (2007) The rat brain in stereotaxic coordinates. 6th Edition. Academic Press, San Diego"},{"key":"6350_CR42","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJA (2002) role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"6350_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-2999(98)00546-9","volume":"356","author":"CM Queiroz","year":"1998","unstructured":"Queiroz CM, Piovezan RD, Frussa-Filho R (1998) Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats. Eur J Pharmacol 356(2\u20133):105\u2013108","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"6350_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0166-4328(96)00164-7","volume":"85","author":"A Ramos","year":"1997","unstructured":"Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviors in six inbred rat strains. Behav Brain Res 85(1):57\u201369","journal-title":"Behav Brain Res"},{"issue":"1\u20132","key":"6350_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0166-4328(98)00023-0","volume":"96","author":"A Ramos","year":"1998","unstructured":"Ramos A, Mellerin Y, Morm\u00e8de P, Chaouloff F (1998) A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res 96(1\u20132):195\u2013205","journal-title":"Behav Brain Res"},{"issue":"5","key":"6350_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.mp.4000546","volume":"4","author":"A Ramos","year":"1999","unstructured":"Ramos A, Moisan MP, Chaouloff F, Morm\u00e8de C, Morm\u00e8de P (1999) Identification of female-specific QTL affecting and emotionality-related behavior in rats. Mol Psychiatry 4(5):453\u2013462","journal-title":"Mol Psychiatry"},{"key":"6350_CR47","doi-asserted-by":"crossref","unstructured":"Ramos A, Granzotto N, Kremer R, Boeder AM, Ara\u00fajo JFP, Pereira AG, Iz\u00eddio GS (2022) Hunting for genes underlying emotionality in the laboratory rat: maps, tools and traps. Curr Neuropharmacol. Online ahead of print","DOI":"10.2174\/1570159X20666220901154034"},{"issue":"12","key":"6350_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","volume":"8","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms. Lancet Neurol 8(12):1128\u20131139","journal-title":"Lancet Neurol"},{"issue":"5","key":"6350_CR49","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","volume":"102","author":"PR Sanberg","year":"1988","unstructured":"Sanberg PR, Bunsey MD, Giordano M, Norman AB (1988) The catalepsy test: its ups and downs. Behav Neurosci 102(5):748\u2013759","journal-title":"Behav Neurosci"},{"key":"6350_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","volume":"253","author":"JR Santos","year":"2013","unstructured":"Santos JR, Cunha JAS, Dierschnabel AL, Camp\u00ealo CL, Le\u00e3o AH, Silva AF, Engelberth RC, Iz\u00eddio GS, Cavalcante JS, Ab\u00edlio VC, Ribeiro AM, Silva RH (2013) Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine. Behav Brain Res 253:68\u201377","journal-title":"Behav Brain Res"},{"issue":"6645","key":"6350_CR51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"key":"6350_CR52","doi-asserted-by":"crossref","unstructured":"S\u00fcdhoF TC, Starke\u00a0K (2008) Pharmacology of neurotransmitter release. In: Handbook of Experimental Pharmacology, vol 184. Springer, p 83\u201387","DOI":"10.1007\/978-3-540-74805-2"},{"issue":"5","key":"6350_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A (2014) IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One\u00a09(5):e96801","journal-title":"PLoS ONE"},{"key":"6350_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.111966","volume":"370","author":"AM Vel\u00e1zquez","year":"2019","unstructured":"Vel\u00e1zquez AM, Roversi K, Dillenburg-Pilla P, Rodrigues RF, Z\u00e1rate-Blad\u00e9s CR, Prediger RDS, Iz\u00eddio GS (2019) The influence of chromosome 4 on metabolism and spatial memory in SHR and SLA16 rat strains. Behav Brain Res 370:111966","journal-title":"Behav Brain Res"},{"issue":"3","key":"6350_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3940(03)00097-1","volume":"340","author":"C Wersinger","year":"2003","unstructured":"Wersinger C, Sidhu A (2003) Attenuation of dopamine transporter activity by \u03b1-synuclein. Neurosci Lett 340(3):189\u2013192","journal-title":"Neurosci Lett"},{"key":"6350_CR56","doi-asserted-by":"crossref","unstructured":"Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A (2015) Mitochondrial dysfunction and \u03b1-synuclein synaptic pathology in Parkinson\u2019s disease: who\u2019s on first? Parkinson\u2019s Disease 2015:ID 108029, 10p","DOI":"10.1155\/2015\/108029"},{"key":"6350_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013217","journal-title":"Ann Neurol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06350-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06350-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06350-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T09:07:16Z","timestamp":1681376836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06350-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6350"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06350-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed following the guidelines for animal care from \u201cConselho Nacional de Controle de Experimenta\u00e7\u00e3o Animal\u201d (CONCEA, Brazil) and following the specifications of the local ethics committee (CEUA\/UFSC, Protocol No. PP00903). The experimental protocol was designed to minimize the number of animals and procedures involving stress, pain, or discomfort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}